A nurse is reinforcing teaching with a client who is to start taking montelukast to treat asthma. Which of the following statements by the client indicates an understanding of the teaching?

A. Acute bronchospasm:

Albuterol (Proventil) is commonly used to treat acute bronchospasm, which is characterized by sudden constriction of the muscles surrounding the airways. This constriction leads to narrowing of the air passages, making it difficult to breathe. Albuterol works as a bronchodilator by relaxing these muscles, thereby opening up the airways and relieving symptoms such as wheezing, shortness of breath, and chest tightness. It is commonly used to manage conditions such as asthma, chronic obstructive pulmonary disease (COPD), and bronchitis, where bronchospasm is a prominent feature.

B. Acute allergies:

Albuterol (Proventil) is not typically used to treat acute allergies. While it can help alleviate symptoms such as wheezing and shortness of breath that may occur as a result of allergic reactions affecting the airways, its primary indication is for bronchospasm associated with respiratory conditions like asthma and COPD. Antihistamines and corticosteroids are more commonly used to manage allergic reactions and their associated symptoms.

C. Nasal congestion:

Albuterol (Proventil) is not indicated for the treatment of nasal congestion. Nasal congestion primarily involves swelling and inflammation of the nasal passages, which are not directly affected by albuterol. Decongestants such as pseudoephedrine or nasal corticosteroids are typically used to relieve nasal congestion by reducing inflammation and swelling in the nasal passages.

D. Dyspnea on exertion:

Albuterol (Proventil) may help alleviate dyspnea (shortness of breath) on exertion, particularly if it is caused by bronchospasm or exercise-induced bronchoconstriction. By relaxing the muscles around the airways, albuterol can improve airflow and ease breathing difficulties associated with exertion. However, it is important to note that albuterol is primarily indicated for the treatment of acute bronchospasm rather than dyspnea on exertion unrelated to bronchospasm. Other interventions, such as oxygen therapy or addressing underlying cardiovascular conditions, may be necessary to manage dyspnea on exertion in those cases.

A. Liver function tests

This is the correct choice. Pyrazinamide, a medication used in the treatment of tuberculosis, is known to potentially cause hepatotoxicity, which refers to liver damage or dysfunction. Therefore, clients prescribed pyrazinamide should undergo regular monitoring of liver function tests to assess for any signs of liver injury or impairment. Liver function tests typically include measurements of various enzymes and proteins produced by the liver, such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), and bilirubin levels.

B. Gallbladder studies

Gallbladder studies are not typically indicated for clients taking pyrazinamide. While pyrazinamide can rarely cause hepatotoxicity, which may affect liver function, it is not known to specifically target or affect the gallbladder. Therefore, routine gallbladder studies are not necessary for clients taking pyrazinamide.

C. Thyroid function studies

Pyrazinamide is not known to directly affect thyroid function. Therefore, routine thyroid function studies are not indicated for clients taking pyrazinamide unless there are specific signs or symptoms suggesting thyroid dysfunction.

D. Blood glucose levels

Pyrazinamide is not known to directly affect blood glucose levels. Therefore, routine monitoring of blood glucose levels is not indicated for clients taking pyrazinamide unless there are specific reasons to suspect or monitor for diabetes mellitus or other conditions affecting blood glucose regulation.